Two Cases of Hemophagocytic Lymphohistiocytosis-Associated AKI in Viral-Triggered Multiorgan Failure (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0376; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She was treated with anakinra, corticosteroids, and rituximab with improved inflammatory markers, but developed dialysis-dependent AKI. AKI occurs in approximately 30–60% of adult HLH cases and is associated with increased mortality, especially when renal replacement therapy is required. Early recognition of HLH in patients with fever, cytopenias, liver injury, hypertriglyceridemia, hyperferritinemia, and AKI is essential, as timely immunomodulation and trigger-directed therapy may improve renal and overall outcomes."
Clinical • Cardiomyopathy • Cardiovascular • Dyslipidemia • Genetic Disorders • Hematological Disorders • Hematological Malignancies • Hemophagocytic lymphohistiocytosis • Hepatology • Hypertriglyceridemia • Hypotension • Immunology • Infectious Disease • Liver Failure • Lymphoma • Metabolic Disorders • Obesity • Peripheral T-cell Lymphoma • Psoriasis • Rare Diseases • Renal Disease • Respiratory Diseases • Septic Shock • T Cell Non-Hodgkin Lymphoma
|
|
Nosagie Ohonba; Aiswarya Menon; Martin Sedlacek
|